New Novel Coronavirus COVID-19 3D Visualization

Gov. Larry Hogan wants hospitals across the state to step up administration of monoclonal antibody treatments, and in Worcester County, health officials are already ahead of the curve.

Heather Snyder, the infection prevention manager at Atlantic General Hospital, said in an email this week that the local health facility was one of the first six sites in Maryland to provide monoclonal antibodies in December 2020, and continues offering the remedies today.

Monoclonal antibody treatments are proven to help treat covid-19. They are given to patients that test positive for the virus to help their bodies produce antibodies to fight it.

Hogan said during a news conference last week that the state is not experiencing a shortage of monoclonal antibodies like some others and he wants clinicians to ramp up their uses of the treatment. According to statistics he provided, the state has administered more than 13,000 of the treatments, which have helped avoid roughly 600 hospitalizations.

Snyder said individuals need to qualify for monoclonal antibody treatments based on criteria from the Maryland Department of Heath. Those who meet the criteria and have a doctor’s order for administration can schedule treatment by calling the hospital’s centralized scheduling line at 410-641-9714. Appointments are scheduled Monday through Friday based on volume.

“Our results fall in line with national trends; benefits include reduction in development of severe disease and hospitalization,” Snyder said.

This story appears in the print version of the Ocean City Today on Oct. 8.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.